ASGCT Annual Meeting
  • Registration
  • Abstracts
    • Submission and Presentation Information
    • Award Recipients
    • Abstract Embargo Policy
    • Awards and Incentives
  • Program
    • Pre-Meeting Workshops: May 10, 2021
    • May 11, 2021
    • May 12, 2021
    • May 13, 2021
    • May 14, 2021
    • Plenary Speakers
  • Sponsor and Exhibit
    • Current Sponsors
    • Pre-Show Exhibitor Listing
  • Media
    • Media Policy
  • Contact Us
  • www.asgct.org
Quick Links
  • ASGCT.org

Connect with us

ASGCT Annual Meeting

  • Registration
  • Abstracts
    • Submission and Presentation Information
    • Award Recipients
    • Abstract Embargo Policy
    • Awards and Incentives
  • Program
    • Pre-Meeting Workshops: May 10, 2021
    • May 11, 2021
    • May 12, 2021
    • May 13, 2021
    • May 14, 2021
    • Plenary Speakers
  • Sponsor and Exhibit
    • Current Sponsors
    • Pre-Show Exhibitor Listing
  • Media
    • Media Policy
  • Contact Us
  • www.asgct.org
×

May 14, 2021

Programming at the Annual Meeting will begin at 9 a.m. ET (6 a.m. PT, 7 a.m. MT, 8 a.m. CT)

All times are listed in Eastern Time (ET). Schedule is subject to change.

Convert the Annual Meeting to Your Time Zone

9-10 a.m. 

Chat Lounge Networking

10-11:45 a.m.

Symposia

  • Newborn Screening: Innovative Policies and Technologies to Eliminate the Diagnostic Odyssey (Government Relations Committee)

  • Safety and Efficacy of Bodywide Therapy for Muscular Skeletal Diseases (Musculo-Skeletal Gene and Cell Therapy Committee)

  • Vaccine Nanotechnology for Rapid Response Applications (Nanoagents and Synthetic Formulations Committee)

  • New Advances in Physical Gene Delivery and Nucleic Acid Vectorology (Physical Delivery, Therapeutics, and Vector Development Committee)

  • Hot Topics and Remaining Challenges in RNAi and Oligonucleotide Therapy for 2021 (Oligonucleotide and RNAi Therapeutics Committee)

  • Race to Respiratory Therapies for COVID-19 (Respiratory and GI Tract Gene and Cell Therapy Committee)

  • RNA Therapies for Neurologic and Ophthalmic Disorders (Neurologic and Ophthalmic Gene and Cell Therapy Committee)

10:45 a.m.-12:15 p.m.

Exhibitor Showcase
Exhibit Hall Open

12:15-2 p.m.

Oral Abstract Session V

2 p.m.

Annual Meeting Concludes

 

 

 

 

 

ASGCT_Web_Horz_Red-White.png

Office

American Society of Gene & Cell Therapy
20800 Swenson Dr.
Suite 300
Waukesha, WI 53186 USA
Tel: 414.278.1341
Fax: 414.276.3349
Email: info@asgct.org

Quick Links

  • ASGCT 2020 Homepage
  • Registration
  • Abstracts
  • Hotel & Travel
  • Program
  • Exhibitors & Sponsors
  • Media
  • Contact ASGCT

Follow Us

© 2021 American Society of Gene & Cell Therapy. All rights reserved.